Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.

AIDS research and human retroviruses - 1 Oct 2009

De Mendoza Carmen, Garrido Carolina, Poveda Eva, Corral Angélica, Zahonero Natalia, Treviño Ana, Anta Lourdes, Soriano Vincent

Abstract excerpt

Natural genetic variability at the pol gene may account for differences in drug susceptibility and selection of resistance patterns across HIV-1 clades. Spread of non-B subtypes along with changes in antiretroviral drug use may have modified drug resistance patterns in recent years. All HIV-1 clinical samples sent to a reference laboratory located in Madrid for drug resistance testing since January 2000 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Cluster Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to pol Gene Products, Human Immunodeficiency Virus

Share to Sequence Homology

Source

Identifiers

PMID: 19842792
DOI: 10.1089/aid.2008.0166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.PMID 19842792Read ↗

Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).Semantic proximity Read ↗

Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in SpainSemantic proximity Read ↗

Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS).Semantic proximity Read ↗

Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010.Semantic proximity Read ↗

Analysis of transmitted drug resistance in Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside drug class.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.Semantic proximity Read ↗

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.Semantic proximity Read ↗

Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain.Semantic proximity Read ↗

Resistance-associated mutation prevalence according to subtypes B and non-B of HIV type 1 in antiretroviral-experienced patients in Minas Gerais, Brazil.Semantic proximity Read ↗

Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years.Semantic proximity Read ↗

Drug resistance in non-subtype B HIV-1.Semantic proximity Read ↗

HIV‐1 subtypes in Spain: a retrospective analysis from 1995 to 2003Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.